// App-Quantinova.ai

: LONG‐TERM EFFICACY OF SUBCUTANEOUS C1‐INHIBITOR IN PATIENTS WITH HEREDITARY ANGIOEDEMA AND VERY HIGH ATTACK BURDEN

Researchers

Presenter

  • Bruce Zuraw

Principal Investigators

  • Timothy Craig

  • Marco Cicardi

  • Hilary Longhurst

  • Henrike Feuersenger

  • Subhransu Prusty

  • Constance Katelaris

Medical Centers

  • Department of Medicine, University of California San Diego, La Jolla, San Diego, CA

  • Department of Medicine, Pediatrics and Graduate Studies, Pennsylvania State University, Hershey, Pennsylvania, USA

  • IRCCS‐ICS Maugeri Milano, University of Milan, Italy

  • Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

  • CSL Behring, Marburg, Germany

  • Immunology and Allergy Unit, Campbelltown Hospital, Campbelltown, NSW, Australia

Locations

  • United States

  • Italy

  • United Kingdom

  • Germany

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Hereditary angioedema

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved